Abstract
Primary cardiac amyloid has a dismal prognosis and most treatments are experimental with highly variable results. Although autologous stem-cell transplant in conjunction with high-dose chemotherapy has yielded regression of amyloid in other body tissues, the presence of cardiac involvement contraindicates stem-cell transfer due to high treatment mortality. We describe the successful treatment of cardiac amyloid using autologous stem-cell transplantation and the resultant regression of the cardiac amyloid.
Original language | English (US) |
---|---|
Pages (from-to) | 746-748 |
Number of pages | 3 |
Journal | Journal of Heart and Lung Transplantation |
Volume | 28 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2009 |
ASJC Scopus subject areas
- Surgery
- Pulmonary and Respiratory Medicine
- Cardiology and Cardiovascular Medicine
- Transplantation